Patents by Inventor Michael J. KATES

Michael J. KATES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250241896
    Abstract: Described herein are novel ?- and ?-propargyl carboxylic acids and esters. The novel compositions are antagonists of CSE and may be used to modulate of the activity of the carotid body, therefore providing therapeutic benefits for sleep-related breathing disorders and related conditions.
    Type: Application
    Filed: March 19, 2025
    Publication date: July 31, 2025
    Applicants: THE UNIVERSITY OF CHICAGO, IIT RESEARCH INSTITUTE
    Inventors: Michael J. KATES, Nanduri B. PRABHAKAR, David L. MCCORMICK, Miguel MUZZIO
  • Patent number: 12280038
    Abstract: Described herein are novel ?- and ?-propargyl carboxylic acids and esters. The novel compositions are antagonists of CSE and may be used to modulate of the activity of the carotid body, therefore providing therapeutic benefits for sleep-related breathing disorders and related conditions.
    Type: Grant
    Filed: June 24, 2022
    Date of Patent: April 22, 2025
    Assignees: The University of Chicago, IIT Research Institute
    Inventors: Michael J. Kates, Nanduri R. Prabhakar, David L. McCormick, Miguel Muzzio
  • Publication number: 20220323415
    Abstract: Described herein are novel ?- and ?-propargyl carboxylic acids and esters. The novel compositions are antagonists of CSE and may be used to modulate of the activity of the carotid body, therefore providing therapeutic benefits for sleep-related breathing disorders and related conditions.
    Type: Application
    Filed: June 24, 2022
    Publication date: October 13, 2022
    Inventors: Michael J. KATES, Nanduri R. PRABHAKAR, David L. MCCORMICK, Miguel MUZZIO
  • Publication number: 20210085648
    Abstract: Described herein are novel ?- and ?-propargyl carboxylic acids and esters. The novel compositions are antagonists of CSE and may be used to modulate of the activity of the carotid body, therefore providing therapeutic benefits for sleep-related breathing disorders and related conditions.
    Type: Application
    Filed: May 6, 2020
    Publication date: March 25, 2021
    Inventors: Michael J. KATES, Nanduri R. PRABHAKAR, David L. MCCORMICK, Miguel MUZZIO